TERN vs VMC · $6.12B cap vs P/E 35, rev $7.42B
Terns Pharmaceuticals Inc (TERN) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
TERN currently screens at market cap $6.12B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the TERN and VMC stock pages for the full models.
Not investment advice.